HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $199,429 | -11.2% | 193,620 | 0.0% | 0.00% | – |
Q2 2023 | $224,599 | -15.9% | 193,620 | +9.5% | 0.00% | – |
Q1 2023 | $267,119 | -39.6% | 176,900 | 0.0% | 0.00% | – |
Q4 2022 | $442,250 | -34.9% | 176,900 | +10.0% | 0.00% | – |
Q3 2022 | $679,000 | +51.2% | 160,800 | 0.0% | 0.00% | – |
Q2 2022 | $449,000 | -79.3% | 160,800 | -57.6% | 0.00% | -100.0% |
Q1 2022 | $2,170,000 | +84.2% | 379,300 | +194.0% | 0.00% | – |
Q4 2021 | $1,178,000 | -23.0% | 129,000 | -9.9% | 0.00% | -100.0% |
Q3 2021 | $1,530,000 | -31.1% | 143,100 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $2,221,000 | -31.8% | 143,100 | -28.8% | 0.00% | 0.0% |
Q1 2021 | $3,256,000 | -23.4% | 200,852 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $4,251,000 | +42.8% | 200,852 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $2,977,000 | -25.5% | 200,852 | -26.1% | 0.00% | 0.0% |
Q2 2020 | $3,996,000 | +30.6% | 271,630 | +4.2% | 0.00% | 0.0% |
Q1 2020 | $3,060,000 | +3.7% | 260,630 | +107.5% | 0.00% | 0.0% |
Q4 2019 | $2,952,000 | +30.3% | 125,600 | +2.5% | 0.00% | +100.0% |
Q3 2019 | $2,266,000 | -0.5% | 122,500 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $2,277,000 | -41.7% | 122,500 | -23.3% | 0.00% | -66.7% |
Q1 2019 | $3,903,000 | +45.8% | 159,693 | +54.7% | 0.00% | +50.0% |
Q4 2018 | $2,677,000 | -18.0% | 103,200 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $3,266,000 | -18.5% | 103,200 | 0.0% | 0.00% | -33.3% |
Q2 2018 | $4,009,000 | +158.0% | 103,200 | +83.3% | 0.00% | +200.0% |
Q1 2018 | $1,554,000 | -22.6% | 56,300 | -49.2% | 0.00% | 0.0% |
Q4 2017 | $2,007,000 | +88.8% | 110,900 | +68.5% | 0.00% | 0.0% |
Q3 2017 | $1,063,000 | +16.7% | 65,800 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $911,000 | +9.0% | 65,800 | +18.1% | 0.00% | 0.0% |
Q1 2017 | $836,000 | +31.0% | 55,700 | +14.4% | 0.00% | 0.0% |
Q4 2016 | $638,000 | -24.0% | 48,700 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $839,000 | -2.0% | 48,700 | +2.7% | 0.00% | 0.0% |
Q2 2016 | $856,000 | -4.9% | 47,400 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $900,000 | -94.7% | 47,400 | -92.5% | 0.00% | -92.9% |
Q4 2015 | $16,937,000 | +14.3% | 634,361 | +4.4% | 0.01% | +7.7% |
Q3 2015 | $14,823,000 | +903.6% | 607,487 | +1181.6% | 0.01% | +1200.0% |
Q2 2015 | $1,477,000 | +2585.5% | 47,400 | +1147.4% | 0.00% | – |
Q1 2015 | $55,000 | +450.0% | 3,800 | +280.0% | 0.00% | – |
Q4 2014 | $10,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2014 | $8,000 | -68.0% | 1,000 | -50.0% | 0.00% | – |
Q2 2014 | $25,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |